niddm Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials
Online Trials
Languages supported at study center
Age Group

Male only (4)
Female only (9)
Any (119)

Phase 0 (3)
Phase 1 (12)
Phase 1/2 (1)
Phase 2 (10)
Phase 3 (6)
Phase 4 (5)
Unknown (85)

Interventional (47)
Observational (37)
INTERVENTIONAL (5)
OBSERVATIONAL (3)

TrialX (6)
Sanofi (5)
Joslin Diabetes Center (3)
Columbia University (2)
Eli Lilly and Company (2)
Second Affiliated Hospital, School of Medicine, Zhejiang University (2)
Seoul National University Hospital (2)
University Hospital, Strasbourg, France (2)
University Hospital, Toulouse (2)
University of Colorado, Denver (2)
University of Leicester (2)
Akros Pharma Inc. (1)
Albert Einstein Healthcare Network (1)
Barmherzige Brüder Linz (1)
Bayer (1)
Canterbury Christ Church University (1)
Centre Hospitalier Universitaire Dijon (1)
Centre Hospitalier Universitaire de la Réunion (1)
Centre Hospitalier de Saint-Denis (1)
Chinese University of Hong Kong (1)
Clinica Especializada en el Manejo de la Diabetes en la Ciudad de Mexico (1)
Derek Richards (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)
Foundation of Cardiovascular Research and Education Enschede (1)
Germans Trias i Pujol Hospital (1)
Geroscience Center for Brain Health and Metabolism (Gero) (1)
Hacettepe University (1)
Hasselt University (1)
Imperial College London (1)
Indiana University (1)
Institut National de la Santé Et de la Recherche Médicale, France (1)
Institut de Recherches Cliniques de Montreal (1)
Jena University Hospital (1)
Jianfeng Xie (1)
Jing Tao (1)
Kinderkrankenhaus auf der Bult (1)
King Abdullah International Medical Research Center (1)
LifeScan Scotland Ltd (1)
Linkoeping University (1)
Massachusetts General Hospital (1)
Max Healthcare Insititute Limited (1)
Metavention (1)
Methodist Health System (1)
NHS Lanarkshire (1)
National Heart Centre Singapore (1)
National Institute of Cardiology, Laranjeiras, Brazil (1)
Newcastle University (1)
Norwegian University of Science and Technology (1)
Novo Nordisk A/S (1)
Oklahoma Medical Research Foundation (1)
Oslo University Hospital (1)
Peking Union Medical College Hospital (1)
Provention Bio, Inc. (1)
Public Health Foundation of India (1)
Rabin Medical Center (1)
Sahlgrenska University Hospital, Sweden (1)
Sanofi Pasteur, a Sanofi Company (1)
Scripps Whittier Diabetes Institute (1)
Shanghai Jiao Tong University School of Medicine (1)
Shiraz University of Medical Sciences (1)
St. Justine's Hospital (1)
Sunnybrook Health Sciences Centre (1)
Suzhou Yabao Pharmaceutical R&D Co., Ltd. (1)
The Cleveland Clinic (1)
The Miriam Hospital (1)
The New York Stem Cell Foundation (1)
The University of Texas Health Science Center at San Antonio (1)
Thomas Jefferson University (1)
TrialX iConnect (1)
University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn) (1)
University Hospital Tuebingen (1)
University of Alberta (1)
University of California, Davis (1)
University of California, San Francisco (1)
University of Chicago (1)
University of Giessen (1)
University of Guadalajara (1)
University of Jordan (1)
University of Texas at Austin (1)
University of Zurich (1)
Uppsala University Hospital (1)
VAXX (1)
Washington University School of Medicine (1)
x sponse (1)

No (102)
Yes (30)

Updated trials (4)

No (131)
Yes (1)

All Languages (6)
English (5)
Arabic (3)
Argentinian Spanish (3)
Asturian (3)
Armenian (2)
Australian English (2)
Albanian (1)
Basque (1)
British English (1)

Adult (18+) (131)
Pediatric (Under 18) (53)

I am/have/had

I am/have/hadglucose intolerance

I am/have/hadendothelial dysfunction

I am/have/hadblood glucose monitoring

I am/have/hadangina pectoris

I am/have/hadamputation of the lower limb

I am/have/hadacute renal failure

I am/have/hadnephropathy

I am/have/hadangiography

I am/have/hadnon-alcoholic fatty liver

I am/have/haddemented

I am/have/hadmild cognitive impairment

I am/have/haddietary intervention

I am/have/hadinsulin resistance

I am/have/hadbiopsy of liver

I am/have/hadcirrhosis

I am/have/hadniddm

I am/have/hadtype 1 diabetes mellitus

I am/have/hadbone densitometry

I am/have/hadcell injury

I am/have/haddementia

added new label for I am/have/had

I am looking for

I am looking fordulaglutide

I am looking formycophenolate

I am looking forantidiabetic agents

I am looking forhdl cholesterol

I am looking forfish oil

I am looking forcytokines

I am looking forsglt2

I am looking fororal hypoglycemic

I am looking forsulfonylurea

I am looking forimmunosuppressive agents

I am looking forangiotensin

I am looking forOnline studies

I am looking forblood sugar

I am looking forsolute carrier family 5 member 2

I am looking forlow density lipoprotein

I am looking forantithymocyte globulin

I am looking forglycosylated hemoglobin

I am looking foreverolimus

I am looking forteplizumab

I am looking forantidiabetic agent

added new label for I am looking for

Advanced Filters

Found 121 clinical trials

For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Effect of Cassia Cinnamon on Arterial Stiffness Parameters in Patients With Type 2 Diabetes Mellitus

Type 2 diabetes mellitus is considered a serious public health problem that has been raising worldwide. In Mexico, it is an important cause of morbi - mortality and its characterized by hyperglycemia that promotes an increase of cardiovascular risk through the impairment of arterial stiffness and endothelial function, which, in …

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus

The main purpose of this study is to evaluate the safety of a study drug known as LY3209590 in Japanese participants with type 2 diabetes. Side effects and tolerability will be documented. Blood samples will be taken to compare how the body handles the drug and how it affects blood …

drug test

body mass index

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age

The purpose of this study is to learn about the interactions of markers of type 2 diabetes (T2DM) and periodontitis (PD). Study VPE00001 is a multi-center cross-sectional study. Participants will be categorized based on point-of-care hemoglobin A1c (HbA1c) and periodontal disease (PD) staging into 9 subgroups.

Accepts healthy volunteers

0 views
14 May, 2025

For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects

The objective of this early feasibility study is to evaluate the safety and performance of intravascular hepatic denervation using the Metavention Integrated Radio Frequency Denervation System (iRF System) to improve glycemic control in type 2 diabetes subjects.

hypertension medication

nash

liver disease

fatty liver

hypertension

0 views
19 Feb, 2024

Includes pre-screening
Phase 1
For Seniors
For adults
all
Recruiting

Internet Intervention for Diabetes Distress.

This study is designed to investigate the potential effectiveness of an internet-delivered intervention for diabetes distress in patients with type 2 diabetes.

Accepts healthy volunteers

0 views
20 Jun, 2025
19 locations

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Endocrinology
Recruiting

Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)

The work proposed pushes the limits of these challenges by providing evidence, identified by a team-based approach to glucose management in an underserved and understudied population supplementing prior data designed to improve outcomes among high-risk patients with type 2 diabetes (T2D) and related cardio metabolic conditions. The proposed intervention is …

hypoglycemia

hypoglycaemic episode

continuous glucose monitoring

poor glycemic control

sugars

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Cardiovascular Diseases
Recruiting

SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

Inhibitors of the sodium-glucose co-transporter (SGLT2) are FDA-approved for the treatment of type 2 diabetes (T2DM). Their mechanism of action involves lowering of blood glucose concentration secondary to increased glucose excretion of glucose by the kidney.

glycosylated hemoglobin

body mass index

oral glucose tolerance test

sglt2

type 2 diabetes mellitus